The agenda for the 15 April 2015 TC meeting is now available. The Commission will consider the following technologies:

• Dulaglutide (Trulicity) - new medicine
• Olaparib (Lynparza) - new medicine
• Nintedanib (Vargatef) - new medicine
• Ozurdex (dexamethasone) - new indication
• Ketosteril (keto acid-amino acid) - new combination product
• Oxycodone hydrochloride with naloxone hydrochloride dihydrate (Targinact) - review of SMR & ASMR

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2015-04/odj_ct_15042015_internet.pdf [French]